1. Home
  2. CRBU vs SMTI Comparison

CRBU vs SMTI Comparison

Compare CRBU & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

HOLD

Current Price

$1.82

Market Cap

203.9M

Sector

Health Care

ML Signal

HOLD

Logo Sanara MedTech Inc.

SMTI

Sanara MedTech Inc.

HOLD

Current Price

$18.85

Market Cap

182.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRBU
SMTI
Founded
2011
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
203.9M
182.6M
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
CRBU
SMTI
Price
$1.82
$18.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$10.00
$41.00
AVG Volume (30 Days)
1.2M
51.7K
Earning Date
06-08-2026
04-20-2026
Dividend Yield
N/A
N/A
EPS Growth
3.64
N/A
EPS
N/A
N/A
Revenue
N/A
$15,586,976.00
Revenue This Year
N/A
$20.66
Revenue Next Year
$5.37
$13.97
P/E Ratio
N/A
N/A
Revenue Growth
N/A
32.47
52 Week Low
$0.66
$18.29
52 Week High
$3.53
$35.70

Technical Indicators

Market Signals
Indicator
CRBU
SMTI
Relative Strength Index (RSI) 51.92 37.65
Support Level $1.71 $18.60
Resistance Level $2.11 $21.18
Average True Range (ATR) 0.15 1.10
MACD -0.01 0.01
Stochastic Oscillator 38.03 19.38

Price Performance

Historical Comparison
CRBU
SMTI

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

About SMTI Sanara MedTech Inc.

Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.

Share on Social Networks: